Comprehensive Report on Quercetin (DB04216)

I. Executive Summary

Quercetin (DrugBank ID: DB04216) is a small molecule flavonol, a subclass of the flavonoid group of polyphenols, that is ubiquitously distributed throughout the plant kingdom.[1] Found in a wide array of common foods such as onions, apples, berries, and tea, it is one of the most abundant antioxidants in the human diet.[3] Decades of preclinical research have positioned Quercetin as a compound of significant scientific interest due to its potent and pleiotropic biological activities, including well-documented antioxidant, anti-inflammatory, immunomodulatory, and anticancer properties demonstrated in numerous

in vitro and animal models.[5]

The central scientific challenge and defining characteristic of Quercetin research is the marked disparity between its robust bioactivity in laboratory settings and its often modest or inconsistent efficacy in human clinical trials.[3] This translational gap is overwhelmingly attributed to a challenging pharmacokinetic profile characterized by very low aqueous solubility, poor oral bioavailability, and rapid, extensive first-pass metabolism in the gut and liver.[3] Upon oral ingestion, the parent Quercetin aglycone is rarely detected in systemic circulation; instead, the body is exposed to a complex profile of conjugated metabolites (glucuronides, sulfates, and methylated forms), raising critical questions about which chemical species are responsible for the observed biological effects.[3]

Mechanistically, Quercetin functions as a powerful free radical scavenger and a modulator of numerous fundamental cellular signaling pathways, including Nuclear Factor-kappa B (NF-κB), Mitogen-Activated Protein Kinase (MAPK), and Phosphatidylinositol 3-kinase (PI3K)/Akt, which govern inflammation, cell survival, and proliferation.[5] This multi-targeted action underpins its investigation across a broad spectrum of pathological conditions, including cardiovascular disease, metabolic disorders, inflammatory conditions like rheumatoid arthritis, allergies, and various cancers.[7]

Current clinical evidence provides a nuanced picture. The most consistent therapeutic benefit observed is a modest but statistically significant reduction in blood pressure in hypertensive individuals.[20] Preliminary positive results have also been noted for symptomatic relief in rheumatoid arthritis.[22] However, for other applications, such as enhancing athletic performance or managing metabolic syndrome, the results are largely inconsistent or clinically insignificant.[21]

From a regulatory standpoint in the United States, Quercetin is available as a dietary supplement and has been designated as Generally Recognized As Safe (GRAS) by the FDA for use as a food ingredient at levels up to 500 mg per serving.[25] However, it is not approved as a therapeutic drug for any condition, and health claims are strictly regulated.[27] A critical aspect of its safety profile is its significant potential for drug-drug interactions, stemming from its ability to inhibit key drug-metabolizing enzymes (Cytochrome P450) and transporters (P-glycoprotein), which can alter the pharmacokinetics of numerous conventional medications.[1]

In conclusion, Quercetin stands as a paradigmatic natural compound: one of high preclinical promise constrained by formidable pharmacokinetic hurdles. Its future therapeutic potential is contingent upon the development of advanced bioavailability-enhancing formulations and a more profound understanding of its metabolic fate and the bioactivity of its metabolites. Until such advances are validated through rigorous, long-term clinical trials, its use should be approached with an appreciation for its modest clinical effects and a significant awareness of its potential for drug interactions.

II. Molecular Profile and Natural Occurrence

Chemical and Physical Characteristics

Quercetin is a naturally occurring plant pigment classified as a pentahydroxyflavone, belonging to the flavonol subclass of flavonoids.[2] Its chemical architecture is foundational to its biological activity, consisting of a C6-C3-C6 backbone with two benzene rings (designated A and B) linked by a three-carbon heterocyclic pyran ring (C).[6] The structure is characterized by five hydroxyl groups located at the 3-, 5-, 7-, 3'-, and 4'-positions, which are key to its antioxidant and metal-chelating properties.[2]

Its systematic International Union of Pure and Applied Chemistry (IUPAC) name is 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one.[2] It is also known by several synonyms, including Sophoretin, Meletin, Quercetine, Quercetol, and Xanthaurine.[3] In its purified form, Quercetin appears as a yellow to green-yellow crystalline powder or as yellow needles, and it possesses a distinctly bitter taste.[2]

A critical physicochemical property governing its biological fate is its solubility. Quercetin is practically insoluble in water, with a reported solubility of less than 0.1 g/100 mL at 21 °C.[3] This poor aqueous solubility is a primary factor limiting its absorption from the gastrointestinal tract and thus its overall bioavailability.[12] While poorly soluble in water, it is soluble in alkaline aqueous solutions, ethanol, glacial acetic acid, acetone, and dimethyl sulfoxide (DMSO).[34] The key identifiers and properties of Quercetin are summarized in Table 1.

Table 1: Chemical and Physical Properties of Quercetin
Identifiers
Common Name	Quercetin
DrugBank ID	DB04216 1
CAS Number	117-39-5 2
PubChem CID	5280343 2
IUPAC Name	2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one 2
InChIKey	REFJWTPEDVJJIY-UHFFFAOYSA-N 2
SMILES	C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O 2
Chemical Formula	C15​H10​O7​ 2
Molecular Weight	302.24 g/mol 34
Physical Properties
Appearance	Yellow crystalline powder or needles 2
Melting Point	~316 °C 3
Solubility	Practically insoluble in water; soluble in ethanol, DMSO, alkaline solutions 3
LogP	1.989 (estimated) 34

Natural Dietary Sources

Quercetin is one of the most widespread and abundant flavonoids in the human diet, with average daily consumption estimated to be between 25–50 mg.[3] It is found in a vast range of plant-based foods, including fruits, vegetables, leaves, seeds, and grains.[3]

The concentration of Quercetin can vary significantly depending on the specific food, the part of the plant, and its growing conditions. For instance, red onions have higher concentrations in their outermost rings and near the root.[3] One study found that organically grown tomatoes contained 79% more Quercetin than conventionally grown ones, suggesting agricultural practices can influence flavonoid content.[3] Some of the richest dietary sources are capers, red onions, kale, asparagus, apples, berries (especially cranberries and blueberries), broccoli, cherries, grapes, and beverages such as green and black tea and red wine.[3]

A crucial distinction in understanding Quercetin's role in nutrition and pharmacology is its chemical form in nature. In plants, Quercetin is rarely found as a free aglycone (the non-sugar part). Instead, it is predominantly present as glycosides, where the Quercetin molecule is attached to one or more sugar moieties.[1] Common examples include rutin (quercetin-3-O-rutinoside), found in buckwheat and citrus fruits, and various quercetin glucosides found in onions.[3] The specific sugar attached and its point of attachment are critical determinants of the molecule's absorption and bioavailability, a topic explored in detail in the pharmacokinetics section. This natural occurrence as a glycoside contrasts with the form often used in dietary supplements and

in vitro research, which is typically the pure aglycone.[3] This fundamental difference complicates the direct comparison of results from epidemiological studies of diet with those from clinical trials using supplements. The food matrix itself, along with the glycosidic structure, actively influences the compound's fate within the body.

Table 2: Prominent Dietary Sources of Quercetin
Food Source	Category	Relative Quercetin Content	Primary Glycosidic Form
Capers	Garnish/Spice	Very High	Rutin, Glucosides 4
Red Onion	Vegetable	High	Glucosides 3
Kale	Vegetable	High	Glycosides 4
Apples (with peel)	Fruit	Medium	Rhamnosides, Galactosides 42
Cranberries	Fruit	Medium	Glycosides 4
Blueberries	Fruit	Medium	Glycosides 4
Broccoli	Vegetable	Medium	Glycosides 4
Green Tea	Beverage	Medium	Rutin, Glucosides 4
Red Wine	Beverage	Medium	Aglycone, Glucosides 4
Buckwheat	Grain	Medium	Rutin 3

III. Pharmacokinetics: The Bioavailability Conundrum

The therapeutic potential of Quercetin is fundamentally constrained by its complex and inefficient pharmacokinetics. The journey of Quercetin from oral ingestion to systemic circulation is marked by poor absorption, extensive metabolism, and rapid elimination, collectively resulting in low bioavailability. This section dissects the ADME (Absorption, Distribution, Metabolism, and Excretion) profile of Quercetin and explores modern strategies designed to overcome these limitations.

Absorption, Distribution, Metabolism, and Excretion (ADME) Profile

Absorption

The oral bioavailability of Quercetin in humans is notoriously low and highly variable among individuals. Estimates of the absorbed fraction range widely, from less than 1% in some studies to approximately 17% in others.[3] This poor absorption is a direct consequence of its low aqueous solubility and the complex interplay between its chemical form and gastrointestinal physiology.

The mechanism of absorption is critically dependent on whether Quercetin is ingested as a free aglycone or as a glycoside.

• Quercetin Aglycone: This form, common in supplements, is lipophilic and is thought to be absorbed primarily via passive diffusion across the intestinal epithelium.[11] However, its poor solubility in the aqueous environment of the gut lumen limits the amount available to diffuse across the cell membrane.
• Quercetin Glycosides: Paradoxically, many glycosidic forms of Quercetin, particularly glucosides found in onions, are absorbed more rapidly and to a greater extent than the aglycone.[45] The prevailing hypothesis is that quercetin-3-O-glucoside can be actively transported into enterocytes via the sodium-dependent glucose transporter-1 (SGLT1).[42] Once inside the cell, the glucose moiety is cleaved by intracellular β-glucosidases, releasing the aglycone. Other glycosides, such as rutin (quercetin-3-O-rutinoside), are too large for this transporter and are poorly absorbed in the small intestine. They transit to the colon, where they are deglycosylated by gut microbial enzymes, releasing the aglycone for potential absorption from the large intestine.[49]

Metabolism

Quercetin undergoes rapid and extensive first-pass metabolism, a process that begins immediately upon absorption into the intestinal enterocytes and continues in the liver.[3] Studies in animal models suggest that the gut wall is the primary site of this metabolic transformation, accounting for over 90% of the initial metabolism.[51]

The metabolic pathways are predominantly Phase II conjugation reactions, which increase the polarity of the molecule to facilitate its excretion. The three main pathways are:

1. Glucuronidation: Catalyzed by UDP-glucuronosyltransferases (UGTs), this is a major metabolic route.[3]
2. Sulfation: Mediated by sulfotransferases (SULTs), this pathway also adds a highly polar sulfate group.[3]
3. Methylation: The catechol-O-methyltransferase (COMT) enzyme methylates one of the hydroxyl groups on the B-ring, forming metabolites like isorhamnetin and tamarixetin.[3]

A profound consequence of this extensive metabolism is that free Quercetin aglycone is virtually undetectable in plasma following oral administration. The chemical species that circulate in the bloodstream are almost exclusively these conjugated metabolites, such as quercetin-3-glucuronide, quercetin-3'-sulfate, and various methylated forms.[3] This reality creates a significant "metabolite paradox." The vast majority of preclinical

in vitro research, which has established Quercetin's potent biological effects, utilizes the free aglycone. However, the human body is primarily exposed to the conjugated metabolites. This raises a critical question: are the metabolites themselves biologically active? Some evidence suggests they retain antioxidant properties, and one report indicates that a methyl metabolite is even more potent than the parent compound in inhibiting macrophage activation.[3] This reframes the concept of metabolism not just as a route of elimination but potentially as a process of bioactivation, creating a suite of different active compounds

in vivo.

Distribution and Excretion

Once in circulation, the conjugated metabolites of Quercetin have a reported plasma half-life of approximately 11–12 hours.[3] In contrast, intravenous injection of the aglycone results in a much more rapid clearance, with a terminal half-life of around 2.4 hours.[3] Animal studies indicate that Quercetin and its metabolites distribute to various tissues, with the highest concentrations found in the lungs, liver, kidneys, and small intestines, and lower levels in the brain, heart, and spleen.[47]

Excretion of the polar metabolites occurs through both renal (urine) and fecal routes.[47] The process is further complicated by the action of efflux transporters, such as Multidrug Resistance-Associated Protein 2 (MRP2), located on the apical membrane of enterocytes. These transporters can actively pump conjugated metabolites from within the cell back into the intestinal lumen, further limiting their systemic bioavailability.[11]

Strategies for Bioavailability Enhancement

The significant challenge posed by Quercetin's pharmacokinetics has spurred the development of numerous strategies aimed at improving its oral bioavailability. These approaches target its low water solubility and high rate of metabolism.

• Advanced Formulation Technologies: Modern drug delivery systems are being employed to enhance the dissolution and absorption of Quercetin. These include:
• Nanotechnology: Nanosuspensions reduce the particle size of Quercetin, increasing its surface area-to-volume ratio and thereby accelerating its dissolution rate in the gut.[54]
• Lipid-Based Systems: Encapsulating Quercetin within liposomes, phytosomes, or lipid-based microemulsions can improve its solubility in the gastrointestinal fluids and facilitate its transport across the intestinal membrane.[46] The use of a Quercetin Phytosome formulation in a recent clinical trial (NCT05297032) exemplifies this approach.[57]
• Inclusion Complexes: Forming complexes with molecules like cyclodextrins can create a hydrophilic exterior around the lipophilic Quercetin molecule, dramatically increasing its water solubility.[12]
• Co-administration with Metabolic Inhibitors: A novel strategy involves co-administering Quercetin with compounds that inhibit the enzymes responsible for its first-pass metabolism or the efflux pumps that expel it from cells. For example, piperine, a compound from black pepper, is known to inhibit both P-glycoprotein and certain CYP450 enzymes, and has been investigated as a bioavailability enhancer for Quercetin.[13]
• Structural Modification: A medicinal chemistry approach involves creating pro-drugs or derivatives of Quercetin by modifying its chemical structure. Adding polar or ionizable groups can improve solubility, while other modifications can disrupt the crystal lattice structure or intramolecular hydrogen bonds that contribute to its poor solubility.[59]

These enhancement strategies, however, reveal a potential strategic conflict. Many of these advanced formulations are designed to maximize the systemic concentration of the free Quercetin aglycone, often by inhibiting the very metabolic pathways that produce the conjugated metabolites.[13] If, as discussed previously, the metabolites are the primary bioactive agents

in vivo, then these strategies could be counterproductive. By preventing the formation of potentially crucial metabolites, they might inadvertently reduce the overall therapeutic effect, even while successfully increasing the plasma concentration of the parent drug. This highlights a critical need for a more sophisticated, metabolomics-informed approach to formulation development, where the goal may not be to maximize aglycone levels but to optimize the profile of bioactive metabolites.

IV. Pharmacodynamics and Molecular Mechanisms of Action

Quercetin exerts its biological effects through a wide array of molecular mechanisms, targeting multiple cellular components and signaling pathways. Its action is not that of a highly specific ligand for a single receptor but rather that of a broad-spectrum modulator of cellular homeostasis, particularly in the context of oxidative stress and inflammation. This pleiotropic activity is the basis for its investigation in a diverse range of diseases.

Antioxidant and Anti-inflammatory Pathways

The most extensively characterized properties of Quercetin are its potent antioxidant and anti-inflammatory activities, which are mediated through both direct and indirect mechanisms.

• Direct Antioxidant Action: Quercetin is a powerful scavenger of reactive oxygen species (ROS), such as superoxide anions and hydroxyl radicals, as well as reactive nitrogen species (RNS) and reactive chlorine species (RCS).[5] This activity is intrinsic to its chemical structure. The o-dihydroxy (catechol) group on the B-ring and the conjugated system formed by the 2,3-double bond and the 4-oxo group on the C-ring allow it to readily donate hydrogen atoms to neutralize free radicals. The resulting Quercetin radical is stabilized by resonance, making it relatively unreactive and effectively terminating radical chain reactions.[7] Furthermore, Quercetin can chelate transition metal ions like iron, which prevents them from catalyzing the Fenton reaction, a major source of hydroxyl radical production.[34]
• Indirect Antioxidant Action: Beyond direct scavenging, Quercetin enhances the body's endogenous antioxidant defense systems. It is a known activator of the Nuclear factor erythroid 2-related factor 2 (Nrf2)-Antioxidant Response Element (ARE) signaling pathway.[5] Activation of Nrf2 leads to the transcriptional upregulation of a suite of protective genes, including those encoding for key antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), and enzymes involved in glutathione (GSH) synthesis and regeneration.[5]
• Anti-inflammatory Mechanisms: Quercetin intervenes in the inflammatory process at multiple key points:
• Inhibition of Pro-inflammatory Enzymes: It inhibits the activity of cyclooxygenase (COX) and lipoxygenase (LOX), enzymes that are critical for the synthesis of pro-inflammatory lipid mediators like prostaglandins and leukotrienes from arachidonic acid.[5]
• Suppression of Cytokine Production: It significantly suppresses the gene expression and production of major pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6), in various cell types.[4]
• Mast Cell Stabilization: It stabilizes the membranes of mast cells and basophils, thereby inhibiting their degranulation and the release of histamine and other mediators that drive allergic and inflammatory responses.[34]

Modulation of Cellular Signaling Cascades

Quercetin's broad effects stem from its ability to influence several fundamental intracellular signaling cascades that regulate cell fate.

• NF-κB Pathway: The Nuclear Factor-kappa B (NF-κB) pathway is a master regulator of genes involved in inflammation and immunity. Quercetin is a potent inhibitor of this pathway. It acts primarily by preventing the phosphorylation and subsequent degradation of the inhibitory protein IκBα. This keeps the NF-κB p50/p65 dimer sequestered in an inactive state in the cytoplasm, preventing its translocation to the nucleus where it would otherwise activate the transcription of pro-inflammatory genes.[16]
• MAPK Pathways: Quercetin modulates the activity of the Mitogen-Activated Protein Kinase (MAPK) signaling pathways, which include p38, c-Jun N-terminal kinase (JNK), and extracellular signal-regulated kinase (ERK). These pathways are integral to cellular responses to a wide range of stimuli, including stress, cytokines, and growth factors, and are involved in regulating inflammation, proliferation, and apoptosis.[16]
• PI3K/Akt/mTOR Pathway: This pathway is a central regulator of cell growth, survival, proliferation, and metabolism. Quercetin has been identified as a direct inhibitor of Phosphatidylinositol 3-kinase (PI3K).[37] By inhibiting PI3K, it blocks the downstream activation of its key effectors, Akt (protein kinase B) and the mammalian target of rapamycin (mTOR). Inhibition of this pathway is a key mechanism underlying Quercetin's observed anti-proliferative and pro-apoptotic effects in cancer cells.[17]
• Other Key Pathways: The regulatory influence of Quercetin extends to other critical pathways. It has been shown to modulate the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway, the Wnt/β-catenin signaling cascade, and to upregulate the activity of the p53 tumor suppressor protein, further contributing to its potential anticancer effects.[17]

Interaction with Specific Biological Targets

In addition to modulating broad signaling networks, Quercetin interacts directly with a variety of specific proteins.

• Enzyme Inhibition: Quercetin is a promiscuous enzyme inhibitor. Beyond COX and LOX, it has been shown to inhibit quinone reductase 2 (QR2) [1], phosphodiesterases (particularly PDE4, which is relevant to its bronchodilatory effects) [37], mitochondrial ATPase [37], xanthine oxidase [62], and fatty acid synthase.[37]
• Transporter and Channel Modulation: It inhibits the function of several ATP-binding cassette (ABC) transporters, including the drug efflux pumps P-glycoprotein (MDR1) and Multidrug Resistance-Associated Protein 1 (MRP1).[28] This property is the basis for many of its drug-drug interactions and its potential to reverse chemotherapy resistance. It also acts as a calmodulin antagonist, which can affect calcium signaling and membrane permeability.[62]
• Cytochrome P450 (CYP) Enzyme Inhibition: In vitro studies have demonstrated that Quercetin is a potent inhibitor of several key drug-metabolizing enzymes, including CYP3A4 and CYP2C19, and a moderate inhibitor of CYP2D6.[3] This inhibitory action is the primary mechanism responsible for its extensive and clinically significant potential for drug-drug interactions.[10]

The sheer breadth of these molecular targets indicates that a simple "one drug, one target" model is insufficient to describe Quercetin's biological activity. Instead, it functions as a "network pharmacological agent," subtly modulating multiple nodes within the complex web of cellular signaling. This network-level activity explains both its broad therapeutic potential across diverse diseases that share common inflammatory and oxidative stress pathways, and the often modest effect sizes observed in clinical settings. Rather than potently inhibiting a single pathway, it appears to gently "re-tune" the cellular response to stress, making it a more likely candidate for prevention and management of chronic, low-grade conditions than for the acute treatment of severe disease.

V. Clinical Evidence and Therapeutic Potential: A Systematic Review

While preclinical studies have established a compelling rationale for the therapeutic use of Quercetin, its translation to clinical practice has been met with mixed success. The following section critically evaluates the available human clinical trial data across various therapeutic areas, consistently contextualizing the findings within the framework of the pharmacokinetic challenges previously discussed.

Cardiovascular Health

The potential cardiovascular benefits of Quercetin are among the most studied, with proposed mechanisms including antioxidant effects (e.g., reducing the oxidation of low-density lipoprotein (LDL)), anti-inflammatory actions within the vasculature, and improvement of endothelial function through pathways like endothelial nitric oxide synthase (eNOS).[7]

• Blood Pressure: This is the area with the most consistent positive evidence. Multiple randomized controlled trials (RCTs) and meta-analyses have concluded that Quercetin supplementation can produce a statistically significant reduction in both systolic and diastolic blood pressure.[4] The effect appears to be most pronounced in individuals with pre-existing hypertension.[75] A "threshold effect" is apparent, with greater efficacy observed in studies using doses of 500 mg/day or higher for durations of eight weeks or longer.[20] The magnitude of the reduction is modest, typically in the range of 3–6 mmHg for systolic blood pressure, but this is considered clinically relevant for cardiovascular risk reduction.[4]
• Lipid Profile: The evidence regarding Quercetin's effect on blood lipids is inconsistent. One study in overweight subjects reported an undesirable decrease in high-density lipoprotein (HDL) cholesterol.[75] In contrast, a sub-group analysis of a meta-analysis suggested that trials lasting eight weeks or more had favorable effects on HDL and triglyceride levels.[20] Another meta-analysis found no significant overall effect on triglycerides or HDL.[21]
• Oxidized LDL: A notable finding from one RCT in overweight individuals was that Quercetin supplementation significantly decreased plasma concentrations of atherogenic oxidized LDL, a key factor in the development of atherosclerosis.[75]

In summary, the strongest clinical evidence for Quercetin in cardiovascular health supports its role as an adjunct therapy for modestly lowering blood pressure. Its effects on other risk markers like lipids require further investigation.

Inflammation and Rheumatic Conditions

Leveraging its potent anti-inflammatory mechanisms, such as the inhibition of TNF-α and the NF-κB pathway, Quercetin has been investigated in inflammatory conditions like rheumatoid arthritis (RA) and osteoarthritis (OA).[4]

• Rheumatoid Arthritis (RA): A key double-blind, placebo-controlled clinical trial involving 50 women with RA demonstrated significant benefits. Supplementation with 500 mg/day of Quercetin for eight weeks led to significant reductions in early morning stiffness, morning pain, and post-activity pain. Furthermore, clinical disease activity scores (DAS-28) and health assessment questionnaire (HAQ) scores improved, and plasma levels of the pro-inflammatory cytokine TNF-α were significantly reduced compared to the placebo group.[4] A broader scoping review identified three studies on RA, which generally reported positive outcomes.[79]
• Osteoarthritis (OA): While human clinical data is limited, preclinical animal models are promising. Studies in rats show that intra-articular injection of Quercetin can protect against cartilage degradation, reduce inflammatory cell infiltration in the joint, and lower levels of inflammatory cytokines in the synovial fluid.[80] A review noted two human studies on OA with positive findings, though details are sparse.[79]

The preliminary evidence for symptomatic relief in RA is encouraging, but larger and longer-duration trials are necessary to confirm these findings and establish its place in management protocols.

Metabolic Health and Diabetes

Preclinical data suggest Quercetin could improve metabolic health by enhancing insulin sensitivity, stimulating glucose uptake in peripheral tissues via pathways involving AMP-activated protein kinase (AMPK) and glucose transporter type 4 (GLUT4), and protecting pancreatic β-cells from oxidative damage.[17]

However, clinical evidence is modest. A meta-analysis of 20 RCTs found that Quercetin supplementation produced a small but statistically significant reduction in fasting plasma glucose (FPG) (weighted mean difference: -1.03 mg/dL). The same analysis found no significant effects on other components of the metabolic syndrome, including triglyceride levels, HDL cholesterol, or waist circumference.[21] Thus, while Quercetin may have a minor beneficial effect on glycemic control, the evidence for a broad impact on metabolic health in humans is currently weak.

Allergies and Respiratory Health

Quercetin's ability to stabilize mast cells and inhibit histamine release, coupled with its capacity to modulate the Th1/Th2 immune balance, makes it a compelling candidate for allergic diseases.[64]

• Allergic Rhinitis: One clinical trial in Japanese adults with seasonal allergies found that 200 mg/day of Quercetin for four weeks significantly improved symptoms of eye itching, sneezing, and nasal discharge compared to placebo.[84]
• Asthma and COPD: While preclinical evidence for its anti-inflammatory and bronchodilatory effects in asthma is strong, human trials are lacking.[64] For Chronic Obstructive Pulmonary Disease (COPD), a Phase 1 clinical trial has established that doses up to 2000 mg/day are safe and well-tolerated in this patient population.[86] A Phase 2 trial (NCT06003270) is currently recruiting to evaluate its biological effects in COPD.[87]
• Gastroesophageal Reflux Disease (GERD): A completed Phase 1 trial (NCT02226484) has explored Quercetin's potential to improve esophageal barrier function, though results are not detailed in the provided materials.[88]

Oncology

Despite a vast body of in vitro research demonstrating Quercetin's multi-targeted anticancer activities—including induction of apoptosis, cell cycle arrest, and inhibition of key cancer-related signaling pathways—the translation to human cancer prevention or treatment remains largely unrealized.[62] Epidemiological studies have suggested a correlation between high dietary flavonoid intake and lower risk for certain cancers, but robust data from human intervention trials is absent.[90] A clinical trial using an intravenous pro-drug of Quercetin in cancer patients was able to achieve detectable plasma levels, but this has not translated into an established therapy.[18]

Athletic Performance and Recovery

Quercetin has been marketed as an ergogenic aid, with the hypothesis that it may boost mitochondrial biogenesis and mitigate exercise-induced oxidative stress.[24] The clinical evidence, however, is highly inconsistent. Some studies have reported minor improvements in endurance performance (e.g., time to exhaustion), but several well-controlled studies have found no benefit over placebo.[10] There is some indication that Quercetin may be more effective at reducing markers of post-exercise muscle damage (e.g., creatine kinase) and inflammation rather than directly enhancing performance.[93]

Emerging Areas of Investigation

Research into Quercetin's therapeutic applications continues to expand. Preclinical studies suggest neuroprotective effects in models of neurodegenerative diseases like Alzheimer's.[4] A notable ongoing Phase 2 clinical trial (NCT05838560) is investigating the combination of Quercetin with the senolytic drug Dasatinib for accelerated aging in mental disorders, including treatment-resistant depression.[96]

Table 3: Summary of Key Clinical Trials and Meta-Analyses for Quercetin
Therapeutic Area	Study Type/Reference	Population	Dosage & Duration	Key Outcomes	Level of Evidence
Cardiovascular (Blood Pressure)	Meta-analysis 20	900 participants	>500 mg/day for >8 weeks	Significant reduction in SBP (~3.09 mmHg) and DBP (~2.86 mmHg)	Moderate
Rheumatoid Arthritis	RCT 22	50 women with RA	500 mg/day for 8 weeks	Significant reduction in pain, stiffness, DAS-28 score, and plasma TNF-α	Low-Moderate
Metabolic Syndrome	Meta-analysis 21	20 RCTs	Varied	Significant reduction in FPG; no effect on lipids, BP, or waist circumference	Low
Allergic Rhinitis	RCT 84	66 adults	200 mg/day for 4 weeks	Significant improvement in eye/nose symptoms and quality of life	Low
Athletic Performance	Systematic Review 93	Athletes/Active individuals	Varied	Inconsistent/conflicting results on performance; some evidence for reduced muscle damage	Low/Conflicting

The pattern emerging from these clinical studies suggests a "threshold effect." Positive outcomes, particularly in cardiovascular and inflammatory conditions, are more consistently reported in trials that employ higher doses (≥500 mg/day) and longer durations (≥8 weeks).[20] This observation aligns with Quercetin's pharmacokinetic profile and network-modulating mechanism. Given its low bioavailability and subtle biological effects, a sufficient cumulative dose over a prolonged period appears necessary to achieve a therapeutic threshold where physiological changes become measurable. This indicates that Quercetin may function more as a long-term dietary modulator than as an acute, potent drug.

VI. Safety, Tolerability, and Drug Interactions

While Quercetin's potential therapeutic benefits are a subject of ongoing research, its safety profile, particularly concerning drug interactions, is a critical consideration for both consumers and healthcare professionals.

Clinical Safety Profile and Adverse Events

Based on numerous human intervention studies, oral Quercetin supplementation is generally considered safe and well-tolerated for short-term use.[4] Doses up to 1 gram (1000 mg) per day have been administered for periods of up to 12 weeks without significant adverse effects.[10] A phase I clinical trial in patients with COPD demonstrated that doses as high as 2000 mg per day were safely tolerated.[86]

When adverse events are reported with oral use, they are typically mild and infrequent. The most common side effects include headache, gastrointestinal upset (e.g., nausea), and paresthesia (tingling sensations in the extremities).[4] The long-term safety of high-dose supplementation (≥1000 mg/day for more than 12 weeks) has not been adequately established, and data are currently unavailable.[10]

Toxicology and High-Dose Concerns

The safety profile of Quercetin is highly dependent on the route of administration. While oral use is generally benign, high-dose intravenous (IV) administration has been associated with more severe toxicities. Reports from early clinical trials in cancer patients noted side effects such as nausea, vomiting, sweating, and dyspnea (shortness of breath). More concerningly, high IV doses (e.g., >945 mg/m²) were linked to nephrotoxicity (kidney damage).[73]

Regarding carcinogenicity, the International Agency for Research on Cancer (IARC) has classified Quercetin in Group 3, meaning it is "not classifiable as to its carcinogenicity to humans," due to inadequate evidence.[34] While some animal studies have raised concerns about its potential to promote tumor growth in specific contexts (e.g., estrogen-dependent cancers) or to exacerbate kidney damage in pre-existing renal disease, these findings have not been substantiated in human studies.[43]

Contraindications and Precautions

Based on the available data, several precautions are warranted:

• Kidney Disease: Individuals with pre-existing kidney problems should avoid Quercetin supplementation. The potential for nephrotoxicity, especially with high doses, and animal data suggesting it could worsen existing damage, make its use in this population contraindicated.[10]
• Pregnancy and Lactation: Due to a lack of sufficient safety data in these populations, Quercetin supplementation should be avoided. Its consumption as a natural component of a balanced diet is considered safe.[4]
• Concomitant Medication Use: Given its extensive potential for drug interactions, individuals taking any prescription medications should consult with a healthcare provider before using Quercetin supplements.

Clinically Significant Drug Interactions

The most significant safety concern for the general population using Quercetin supplements is its vast potential for drug-drug interactions. These interactions are not incidental; they are a direct consequence of the same molecular mechanisms that underlie its biological activity, namely the inhibition of key drug-metabolizing enzymes and transport proteins.

• Mechanism of Interaction: In vitro data have firmly established Quercetin as a potent inhibitor of:
• Cytochrome P450 (CYP) Enzymes: It inhibits major drug-metabolizing enzymes, including CYP3A4, CYP2C19, CYP2D6, CYP2C8, and CYP2C9.[3] By inhibiting these enzymes, Quercetin can slow the metabolism of numerous drugs, leading to increased plasma concentrations and a heightened risk of toxicity.
• Drug Efflux Transporters: It inhibits the function of P-glycoprotein (P-gp, also known as MDR1) and other transporters like MRP1 and Organic Anion Transporters (OATs).[10] These transporters are crucial for pumping drugs out of cells and facilitating their excretion. Inhibition can lead to increased intracellular drug accumulation and higher systemic exposure.

This broad inhibitory profile means Quercetin can potentially interact with a wide range of medications. The perception of "natural" supplements as inherently safe is particularly misleading in the case of Quercetin. Its potent biochemical activity makes it a pharmacologically active agent, and the risk of drug interactions is significant and likely underappreciated by consumers. This underscores a critical need for clear interaction warnings on supplement labels and enhanced education for clinicians and pharmacists.

Table 4: Documented and Potential Drug Interactions with Quercetin
Interacting Drug/Class	Mechanism of Interaction	Potential Clinical Outcome	Reference(s)
Warfarin (Coumadin)	Inhibition of CYP2C9; displacement from plasma protein binding	Increased INR, heightened risk of bleeding	10
Cyclosporine	Inhibition of CYP3A4 and P-glycoprotein	Increased cyclosporine levels and risk of toxicity	10
Antihypertensive Drugs	Additive vasodilatory effects	Blood pressure may become too low (hypotension)	10
Quinolone Antibiotics (e.g., Ciprofloxacin)	Potential inhibition of bacterial DNA gyrase binding	Decreased antibiotic effectiveness	10
Digoxin	Inhibition of P-glycoprotein efflux	Increased digoxin levels and risk of toxicity	73
Various Chemotherapy Agents (e.g., Paclitaxel, Doxorubicin, Topotecan)	Inhibition of CYP3A4 and P-glycoprotein	Increased drug exposure, potentially enhancing both efficacy and toxicity	100
Statins (e.g., Atorvastatin)	Inhibition of CYP3A4 metabolism / P-gp transport	Increased statin levels and risk of myopathy	1
Antidiabetes Drugs	Additive glucose-lowering effects	Blood sugar may become too low (hypoglycemia)	10

VII. Regulatory Landscape and Consumer Guidance

The regulation and marketing of Quercetin exist in a nuanced space between a food ingredient and a potential therapeutic agent, which has important implications for consumers and healthcare providers.

Regulatory Status

• United States (Food and Drug Administration - FDA):
• Quercetin is primarily sold and regulated as a dietary supplement. Under the Dietary Supplement Health and Education Act of 1994 (DSHEA), supplements are not subject to the rigorous pre-market safety and efficacy testing required for pharmaceutical drugs.[92]
• In 2010, the FDA reviewed a Generally Recognized As Safe (GRAS) notification (GRN No. 341) submitted for a highly purified form of Quercetin (QU995). The FDA responded with a "no questions" letter, acknowledging its safety for use as an ingredient in specific food categories, including beverages, grain products, and soft candies, at levels up to 500 milligrams per serving.[25] This GRAS status applies specifically to its use as a food ingredient and does not constitute an endorsement of any therapeutic claims.
• The FDA strictly prohibits manufacturers from marketing supplements with claims that they can diagnose, treat, cure, or prevent any disease. Such claims would classify the product as an unapproved new drug. This was demonstrated in a 2020 warning letter issued to FRS International, LLC, for marketing Quercetin-containing products with explicit claims to prevent or treat COVID-19.[27] The FDA deemed these products to be unapproved and misbranded drugs sold in violation of the Federal Food, Drug, and Cosmetic Act.[27]
• Other Regions: The provided research materials do not contain specific details on the regulatory status of Quercetin under the European Medicines Agency (EMA) or other international bodies. One database search noted a lack of drug labels from the EMA that contained pharmacogenomic information related to Quercetin, which is consistent with its status as a supplement rather than an approved pharmaceutical.[110]

This regulatory framework creates a "tightrope" for manufacturers and consumers. The scientific interest in Quercetin is driven by its potential health benefits, yet manufacturers are legally barred from making explicit therapeutic claims. This often results in vague marketing language, such as "supports immune function" or "promotes cardiovascular health," leaving consumers to navigate the complex and often conflicting scientific literature to understand the product's true potential and risks.

Dosage and Formulation in Clinical Use and Supplements

• Dosage: There is no official recommended daily intake for Quercetin. In clinical trials, oral dosages have varied widely, but a typical range is 500 mg to 1000 mg per day, often administered in divided doses.[10] Some studies have used lower doses (e.g., 150-200 mg/day), while safety trials have tested doses as high as 2000 mg/day.[75] The average dietary intake is much lower, estimated at 25-50 mg per day.[3]
• Formulation: Quercetin supplements are widely available in various forms, including capsules, tablets, and powders.[83] The chemical form can be the free aglycone or a glycoside like rutin. Recognizing the bioavailability challenge, many commercial formulations incorporate other compounds intended to enhance absorption, such as bromelain (a digestive enzyme from pineapple) or vitamin C, although robust clinical evidence supporting the efficacy of these specific combinations is not detailed in the provided materials.[4] More advanced, scientifically-driven formulations, such as phytosomes (a complex of Quercetin with phospholipids), are also being used in clinical trials (e.g., NCT05297032) and are available commercially, with the explicit goal of improving absorption and bioavailability.[57]

VIII. Synthesis and Future Perspectives

Quercetin is a biochemically potent and pleiotropic flavonol, whose extensive preclinical profile suggests a wide range of health benefits, particularly stemming from its antioxidant and anti-inflammatory properties. It acts as a network pharmacological agent, subtly modulating key cellular signaling pathways that are fundamental to homeostasis and disease pathogenesis. This multi-targeted mechanism provides a strong rationale for its potential utility in preventing and managing chronic conditions characterized by low-grade inflammation and oxidative stress.

However, the translation of this preclinical promise into consistent and robust clinical efficacy remains the dominant challenge in the field. This translational gap is overwhelmingly dictated by Quercetin's challenging pharmacokinetic profile. Its very low oral bioavailability, which is highly variable and dependent on its chemical form (aglycone vs. glycoside), combined with rapid and extensive first-pass metabolism, means that the body's systemic exposure to the parent compound is minimal. The central, unresolved question is whether the biological effects observed in vivo are attributable to trace amounts of the parent aglycone or, more plausibly, to the complex array of conjugated metabolites that are the primary circulating species. This "metabolite paradox" casts a shadow over the direct relevance of much of the existing in vitro data, which has almost exclusively used the aglycone form.

Based on this comprehensive analysis, several key directions for future research are essential to clarify and potentially unlock the therapeutic potential of Quercetin:

1. Systematic Evaluation of Metabolite Bioactivity: The highest priority for future research should be to move beyond the aglycone-centric model. A concerted effort is needed to synthesize the major circulating metabolites of Quercetin (e.g., quercetin-3-glucuronide, quercetin-3'-sulfate, isorhamnetin) and systematically evaluate their biological activities in vitro and in vivo. Understanding the pharmacodynamics of these metabolites is paramount to deciphering Quercetin's true mechanism of action in the human body.
2. Clinically Validated Bioavailability-Enhanced Formulations: Future clinical trials should transition from using standard Quercetin aglycone to employing advanced formulations (e.g., phytosomes, nanoparticles, self-emulsifying systems) that have demonstrated superior absorption in human pharmacokinetic studies. Trials such as NCT05297032, which utilizes a phytosome formulation, represent a critical step in this direction.[57] This will help determine if overcoming the bioavailability hurdle can translate into more significant clinical outcomes.
3. Long-Term, High-Dose Safety Studies: While short-term safety at moderate doses is well-established, the increasing popularity of high-dose supplementation necessitates dedicated long-term safety studies (i.e., >12 weeks). These studies are crucial to address the preclinical concerns regarding potential nephrotoxicity and hormonal effects, and to better characterize the risk profile in real-world usage scenarios.[43]
4. Targeted and Well-Designed Clinical Trials: Future efficacy trials should be designed with the "threshold effect" in mind, prioritizing longer intervention periods (e.g., >8 weeks) and adequate dosages (e.g., >500 mg/day). Furthermore, trials should focus on populations with existing, measurable pathologies (e.g., hypertension, rheumatoid arthritis) where a clinical signal is more likely to be detected, rather than in healthy, young individuals where baseline function is already optimal.

In its current state, Quercetin is best characterized as a dietary supplement with a strong safety profile for short-term oral use and evidence for modest, context-dependent benefits, most notably in blood pressure reduction. Its ultimate role in clinical therapeutics is uncertain. The convergence of advanced pharmaceutical formulation science with a deeper, metabolomics-driven understanding of its pharmacology may yet elevate Quercetin from a popular nutraceutical to a validated therapeutic agent. Until then, its use must be guided by a realistic appraisal of its current evidence base and a vigilant awareness of its significant potential for drug-drug interactions.

Works cited

1. Quercetin: Uses, Interactions, Mechanism of Action | DrugBank Online, accessed August 28, 2025, https://go.drugbank.com/drugs/DB04216
2. Quercetin | C15H10O7 | CID 5280343 - PubChem, accessed August 28, 2025, https://pubchem.ncbi.nlm.nih.gov/compound/Quercetin
3. Quercetin - Wikipedia, accessed August 28, 2025, https://en.wikipedia.org/wiki/Quercetin
4. Quercetin: Benefits, Side Effects, Dosage, and Foods - Healthline, accessed August 28, 2025, https://www.healthline.com/nutrition/quercetin
5. Quercetin, a Flavonoid with Great Pharmacological Capacity - MDPI, accessed August 28, 2025, https://www.mdpi.com/1420-3049/29/5/1000
6. Pharmacological Activity of Quercetin: An Updated Review - PMC, accessed August 28, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC9731755/
7. Recent Advances in Potential Health Benefits of Quercetin - PMC - PubMed Central, accessed August 28, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10384403/
8. Multipotent bioflavonoid quercetin: Molecular targets and mechanism of action and nanotechnology applications in cancer, metabolic diseases and aging - Scholars @ UT Health San Antonio, accessed August 28, 2025, https://scholars.uthscsa.edu/es/publications/multipotent-bioflavonoid-quercetin-molecular-targets-and-mechanis
9. Pharmacokinetics and bioavailability of the flavonol quercetin in humans - ResearchGate, accessed August 28, 2025, https://www.researchgate.net/publication/12934632_Pharmacokinetics_and_bioavailability_of_the_flavonol_quercetin_in_humans
10. QUERCETIN: Overview, Uses, Side Effects, Precautions, Interactions, Dosing and Reviews, accessed August 28, 2025, https://www.webmd.com/vitamins/ai/ingredientmono-294/quercetin
11. Bioavailability of Quercetin - Current Research in Nutrition and Food Science, accessed August 28, 2025, https://www.foodandnutritionjournal.org/vol04nospl-issue-conf-october-2016/bioavailability-of-quercetin/
12. A Systematic Review: Quercetin—Secondary Metabolite of the Flavonol Class, with Multiple Health Benefits and Low Bioavailability - PMC - PubMed Central, accessed August 28, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC11594109/
13. Full article: Enhancement of oral bioavailability of quercetin by metabolic inhibitory nanosuspensions compared to conventional nanosuspensions - Taylor & Francis Online, accessed August 28, 2025, https://www.tandfonline.com/doi/full/10.1080/10717544.2021.1927244
14. A Review of Quercetin: Chemistry, Antioxidant Properties, and Bioavailability, accessed August 28, 2025, https://www.jyi.org/2009-april/2017/10/15/a-review-of-quercetin-chemistry-antioxidant-properties-and-bioavailability
15. Transit and Metabolic Pathways of Quercetin in Tubular Cells: Involvement of Its Antioxidant Properties in the Kidney - PMC - PubMed Central, accessed August 28, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC8228652/
16. Molecular Targets Underlying the Anticancer Effects of Quercetin: An Update - MDPI, accessed August 28, 2025, https://www.mdpi.com/2072-6643/8/9/529
17. The most important signalling pathways affected by quercetin during... - ResearchGate, accessed August 28, 2025, https://www.researchgate.net/figure/The-most-important-signalling-pathways-affected-by-quercetin-during-cancer-prevention-A_fig1_362705401
18. Quercetin as a Therapeutic Product: Evaluation of Its Pharmacological Action and Clinical Applications—A Review - PMC, accessed August 28, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10674654/
19. The Effects of Quercetin on Vascular Endothelium, Inflammation, Cardiovascular Disease and Lipid Metabolism—A Review - MDPI, accessed August 28, 2025, https://www.mdpi.com/2072-6643/17/9/1579
20. Meta-analysis finds that quercetin significantly lowers blood pressure. Digest, accessed August 28, 2025, https://www.foundmyfitness.com/stories/qgl2kf/meta-analysis_finds_that_quercetin_significantly_lowers_blood_pressure
21. The effect of quercetin supplementation on the components of metabolic syndrome in adults: A systematic review and dose–response meta -analysis of randomized controlled trials - Bohrium, accessed August 28, 2025, https://www.bohrium.com/paper-details/the-effect-of-quercetin-supplementation-on-the-components-of-metabolic-syndrome-in-adults-a-systematic-review-and-dose-response-meta-analysis-of-randomized-controlled-trials/986086411851530250-1448
22. The Effect of Quercetin on Inflammatory Factors and Clinical Symptoms in Women with Rheumatoid Arthritis: A Double-Blind - University of Alabama at Birmingham, accessed August 28, 2025, https://www.uab.edu/medicine/rheumatology/images/JY_-_Javade_et_al_2016.pdf
23. Does Quercetin Improve Endurance Performance?, accessed August 28, 2025, https://humanperformanceresourcecenter.org/dietary-supplements/hprc-articles/does-quercetin-improve-endurance-performance/
24. Study: Popular supplement quercetin does not enhance athletic performance - UGA Today, accessed August 28, 2025, https://news.uga.edu/study-popular-supplement-quercetin-does-not-enhance-athletic-performance/
25. A critical evaluation of risk to reward ratio of quercetin supplementation for COVID‐19 and associated comorbid conditions - PMC - PubMed Central, accessed August 28, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC9111035/
26. Quercetin - GRAS Notices - FDA, accessed August 28, 2025, https://www.cfsanappsexternal.fda.gov/scripts/fdcc/?set=GRASNotices&id=341
27. FRS International, LLC - 606701 - 06/15/2020 | FDA, accessed August 28, 2025, https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/frs-international-llc-606701-06152020
28. Showing BioInteractions for Quercetin (DB04216) | DrugBank Online, accessed August 28, 2025, https://go.drugbank.com/drugs/DB04216/biointeractions
29. A critical review on quercetin bioflavonoid and its derivatives: Scope, synthesis, and biological applications with future prospects - Arabian Journal of Chemistry, accessed August 28, 2025, https://arabjchem.org/a-critical-review-on-quercetin-bioflavonoid-and-its-derivatives-scope-synthesis-and-biological-applications-with-future-prospects/
30. Research progress of quercetin in cardiovascular disease - PMC - PubMed Central, accessed August 28, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10694509/
31. Quercetin (C15H10O7) - PubChemLite, accessed August 28, 2025, https://pubchemlite.lcsb.uni.lu/e/compound/5280343
32. CAS 117-39-5 Quercetin - Alfa Chemistry, accessed August 28, 2025, https://www.alfa-chemistry.com/product/quercetin-cas-117-39-5-289723.html
33. Quercetin - PubChem, accessed August 28, 2025, https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=135269910
34. Quercetin | 117-39-5 - ChemicalBook, accessed August 28, 2025, https://www.chemicalbook.com/ChemicalProductProperty_EN_CB3230765.htm
35. CAS Number 117-39-5 | Quercetin - Spectrum Chemical, accessed August 28, 2025, https://www.spectrumchemical.com/cas/117-39-5
36. Quercetin as a therapeutic product: evaluation of its pharmacological action and clinical applications—a review - Queen's University Belfast, accessed August 28, 2025, https://pureadmin.qub.ac.uk/ws/portalfiles/portal/539591394/pharmaceuticals_16_01631_v2_1_.pdf
37. Quercetin 95 (HPLC), solid, 117-39-5 Sigma-Aldrich, accessed August 28, 2025, https://www.sigmaaldrich.com/US/en/product/sigma/q4951
38. Promising bioactive properties of quercetin for potential food applications and health benefits: A review - PubMed Central, accessed August 28, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC9748429/
39. 20 Whole Food Sources of Quercetin — Functional Health Research + Resources, accessed August 28, 2025, https://madewholenutrition.com/blog/20-whole-food-sources-of-quercetin
40. Where Can I Find Quercetin in Foods? - Gaia Herbs, accessed August 28, 2025, https://www.gaiaherbs.com/blogs/seeds-of-knowledge/where-can-i-find-quercetin-foods
41. Botanical Flavonoids: Efficacy, Absorption, Metabolism and Advanced Pharmaceutical Technology for Improving Bioavailability - MDPI, accessed August 28, 2025, https://www.mdpi.com/1420-3049/30/5/1184
42. (PDF) Bioavailability of Quercetin - ResearchGate, accessed August 28, 2025, https://www.researchgate.net/publication/309603709_Bioavailability_of_Quercetin
43. Safety Aspects of the Use of Quercetin as a Dietary Supplement - ResearchGate, accessed August 28, 2025, https://www.researchgate.net/publication/321014123_Safety_Aspects_of_the_Use_of_Quercetin_as_a_Dietary_Supplement
44. Top Ten Foods High in Quercetin and How to Prepare Them - Seeking Health, accessed August 28, 2025, https://www.seekinghealth.com/blogs/education/top-ten-foods-high-in-quercetin-and-how-to-prepare-them
45. Pharmacokinetics of Quercetin Absorption from Apples and Onions in Healthy Humans - UC Davis, accessed August 28, 2025, https://mitchell.ucdavis.edu/sites/g/files/dgvnsk916/files/2017-05/2012%20QUercetin%20pharmacokinetics%20Lee.pdf
46. Neuropharmacological Effects of Quercetin: A Literature-Based Review - Frontiers, accessed August 28, 2025, https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.665031/full
47. The Pharmacological Activity, Biochemical Properties, and Pharmacokinetics of the Major Natural Polyphenolic Flavonoid: Quercetin - MDPI, accessed August 28, 2025, https://www.mdpi.com/2304-8158/9/3/374
48. Dietary Quercetin and Kaempferol: Bioavailability and Potential Cardiovascular-Related Bioactivity in Humans - MDPI, accessed August 28, 2025, https://www.mdpi.com/2072-6643/11/10/2288
49. Bioavailability of Quercetin - Current Research in Nutrition and Food Science, accessed August 28, 2025, https://www.foodandnutritionjournal.org/pdf/vol4noSpecialissue/Vol4_Conference_Spl(1)_p_146-151.pdf
50. Bioavailability of Quercetin in Humans with a Focus on Interindividual Variation - Pure, accessed August 28, 2025, https://researchmgt.monash.edu/ws/portalfiles/portal/256521175/256521066_oa.pdf
51. Pharmacokinetics and Modeling of Quercetin and Metabolites | Request PDF - ResearchGate, accessed August 28, 2025, https://www.researchgate.net/publication/7794575_Pharmacokinetics_and_Modeling_of_Quercetin_and_Metabolites
52. Pharmacokinetics and Bioavailability of Quercetin Glycosides in Humans - Semantic Scholar, accessed August 28, 2025, https://www.semanticscholar.org/paper/Pharmacokinetics-and-Bioavailability-of-Quercetin-Graefe-Wittig/7b036a019c1f4aee1af703a6d534f0713f5968c4
53. Unlocking the power of Quercetin: A guide to its biological activity, accessed August 28, 2025, https://www.plantsjournal.com/archives/2025/vol13issue2/PartA/13-2-5-969.pdf
54. Enhancement of oral bioavailability of quercetin by metabolic inhibitory nanosuspensions compared to conventional nanosuspensions - PMC, accessed August 28, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC8218931/
55. Improving quercetin bioavailability: A systematic review and meta- analysis of human intervention studies - Queen's University Belfast, accessed August 28, 2025, https://pure.qub.ac.uk/files/646340745/azzzz.pdf
56. Enhanced Bioavailability and Pharmacokinetics of a Natural Self-Emulsifying Reversible Hybrid-Hydrogel System of Quercetin: A Randomized Double-Blinded Comparative Crossover Study | ACS Omega, accessed August 28, 2025, https://pubs.acs.org/doi/10.1021/acsomega.2c05929
57. Study Details | Effects of Quercetin on Metabolic Health - ClinicalTrials.gov, accessed August 28, 2025, https://clinicaltrials.gov/study/NCT05297032?term=AREA%5BBasicSearch%5D(Quercetin)&rank=3
58. Study Details | Effects of Quercetin on Metabolic Health - ClinicalTrials.gov, accessed August 28, 2025, https://www.clinicaltrials.gov/study/NCT05297032?intr=QUERCETIN&aggFilters=studyType:int&viewType=Table&rank=5
59. Drug design strategies that aim to improve the low solubility and poor bioavailability conundrum in quercetin derivatives - PubMed, accessed August 28, 2025, https://pubmed.ncbi.nlm.nih.gov/37515777/
60. Drug design strategies that aim to improve the low solubility and poor bioavailability conundrum in quercetin derivatives - Taylor & Francis Online, accessed August 28, 2025, https://www.tandfonline.com/doi/abs/10.1080/17460441.2023.2241366
61. Quercetin, the Potential Powerful Flavonoid for Human and Food: A Review - IMR Press, accessed August 28, 2025, https://www.imrpress.com/journal/fbe/16/3/10.31083/j.fbe1603030
62. (PDF) A review of quercetin: Antioxidant and anticancer properties - ResearchGate, accessed August 28, 2025, https://www.researchgate.net/publication/267333748_A_review_of_quercetin_Antioxidant_and_anticancer_properties
63. Why Moringa oleifera is Called the Miracle Tree: Health Benefits for Immunity, Inflammation, and Metabolism - News-Medical, accessed August 28, 2025, https://www.news-medical.net/health/How-moringa-supports-immunity-inflammation-and-metabolic-health.aspx
64. Quercetin and Its Lecithin-Based Formulation: Potential Applications for Allergic Diseases Based on a Narrative Review - MDPI, accessed August 28, 2025, https://www.mdpi.com/2072-6643/17/9/1476
65. Quercetin and Its Anti-Allergic Immune Response - PMC - PubMed Central, accessed August 28, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC6273625/
66. Quercetin (Pubchem CID : 5280343) (a) 3D Structure (b) 2D Structure Molecular Formula : C15H10O7 MW : 302.2357 g/mol - ResearchGate, accessed August 28, 2025, https://www.researchgate.net/figure/Quercetin-Pubchem-CID-5280343-a-3D-Structure-b-2D-Structure-Molecular-Formula_fig3_291347577
67. Quercetin Can Improve Spinal Cord Injury by Regulating the mTOR Signaling Pathway - Frontiers, accessed August 28, 2025, https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2022.905640/full
68. Potential Therapeutic Targets of Quercetin, a Plant Flavonol, and Its Role in the Therapy of Various Types of Cancer through the Modulation of Various Cell Signaling Pathways - PMC - PubMed Central, accessed August 28, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC7957552/
69. Potential Therapeutic Targets of Quercetin, a Plant Flavonol, and Its Role in the Therapy of Various Types of Cancer through the Modulation of Various Cell Signaling Pathways - MDPI, accessed August 28, 2025, https://www.mdpi.com/1420-3049/26/5/1315
70. A Comprehensive Analysis and Anti-Cancer Activities of Quercetin in ROS-Mediated Cancer and Cancer Stem Cells - MDPI, accessed August 28, 2025, https://www.mdpi.com/1422-0067/23/19/11746
71. Quercetin Dihydrate | C15H14O9 | CID 5284452 - PubChem, accessed August 28, 2025, https://pubchem.ncbi.nlm.nih.gov/compound/Quercetin-Dihydrate
72. Quercetin acutely relaxes airway smooth muscle and potentiates β-agonist-induced relaxation via dual phosphodiesterase inhibition of PLCβ and PDE4 - PubMed Central, accessed August 28, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC3763034/
73. Indication-specific dosing for (quercetin), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and cost information. - Medscape Reference, accessed August 28, 2025, https://reference.medscape.com/drug/quercetin-344495
74. Potential Pharmaceutical Applications of Quercetin in Cardiovascular Diseases - MDPI, accessed August 28, 2025, https://www.mdpi.com/1424-8247/15/8/1019
75. Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study | British Journal of Nutrition - Cambridge University Press & Assessment, accessed August 28, 2025, https://www.cambridge.org/core/journals/british-journal-of-nutrition/article/quercetin-reduces-systolic-blood-pressure-and-plasma-oxidised-lowdensity-lipoprotein-concentrations-in-overweight-subjects-with-a-highcardiovascular-disease-risk-phenotype-a-doubleblinded-placebocontrolled-crossover-study/8DB47B7FB4C09E5D3995A2F3F577D473
76. Quercetin benefits, dosage, and side effects - Examine.com, accessed August 28, 2025, https://examine.com/supplements/quercetin/
77. Pathways of Inflammation | Download Scientific Diagram - ResearchGate, accessed August 28, 2025, https://www.researchgate.net/figure/Pathways-of-Inflammation_fig1_362219827
78. Potential Implications of Quercetin in Autoimmune Diseases - Frontiers, accessed August 28, 2025, https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.689044/full
79. Quercetin supplementation in rheumatological diseases: a scoping review, accessed August 28, 2025, https://www.beyond-rheumatology.org/wp-content/uploads/sites/10/2024/07/e533.pdf
80. Quercetin prevents osteoarthritis progression possibly via regulation of local and systemic inflammatory cascades - PMC - PubMed Central, accessed August 28, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC9930437/
81. Potential of Quercetin as a Promising Therapeutic Agent Against Type 2 Diabetes - MDPI, accessed August 28, 2025, https://www.mdpi.com/1420-3049/30/15/3096
82. Exploring the mechanistic pathways of promising bioflavonoid Quercetin in diabetes management - Natural Resources for Human Health, accessed August 28, 2025, https://www.nrfhh.com/Exploring-the-mechanistic-pathways-of-promising-bioflavonoid-Quercetin-in-diabetes,191951,0,2.html
83. Longevity, health, anti inflammation with quercetin, accessed August 28, 2025, https://www.howardhealthandwellness.com/post/quercetin-health-antiinflammation/
84. How Quercetin Works for Allergies - Rupa Health, accessed August 28, 2025, https://www.rupahealth.com/post/quercetin-for-allergies-how-quercetin-works-for-allergies
85. Quercetin as Drug to Treat Asthma - What is Missing? - Austin Publishing Group, accessed August 28, 2025, https://austinpublishinggroup.com/asthma/fulltext/asthma-v1-id1002.php
86. Randomised clinical trial to determine the safety of quercetin supplementation in patients with chronic obstructive pulmonary disease | BMJ Open Respiratory Research, accessed August 28, 2025, https://bmjopenrespres.bmj.com/content/7/1/e000392
87. Chronic Obstructive Pulmonary Disease Recruiting Phase 2 Trials for Quercetin (DB04216), accessed August 28, 2025, https://go.drugbank.com/indications/DBCOND0027923/clinical_trials/DB04216?phase=2&status=recruiting
88. Acid Reflux Completed Phase 1 Trials for Quercetin (DB04216) | DrugBank Online, accessed August 28, 2025, https://go.drugbank.com/indications/DBCOND0059843/clinical_trials/DB04216?phase=1&status=completed
89. Reflux Acid Completed Phase 1 Trials for Quercetin (DB04216) | DrugBank Online, accessed August 28, 2025, https://go.drugbank.com/indications/DBCOND0135974/clinical_trials/DB04216?phase=1&status=completed
90. Effects of low dose quercetin: Cancer cell-specific inhibition of cell cycle progression - PMC, accessed August 28, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC2736626/
91. Full article: Anticancer and apoptosis inducing potential of quercetin against a wide range of human malignancies, accessed August 28, 2025, https://www.tandfonline.com/doi/full/10.1080/10942912.2023.2252619
92. Quercetin: Uses, Health Benefits, Dosage and Side Effects - WebMD, accessed August 28, 2025, https://www.webmd.com/vitamins-and-supplements/quercetin-uses-and-risks
93. Quercetin in Sports and Exercise: A review - PMC - PubMed Central, accessed August 28, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10824311/
94. Does Flavonoid Consumption Improve Exercise Performance? Is It Related to Changes in the Immune System and Inflammatory Biomarkers? A Systematic Review of Clinical Studies since 2005 - MDPI, accessed August 28, 2025, https://www.mdpi.com/2072-6643/13/4/1132
95. Does quercetin and vitamin C improve exercise performance, muscle damage, and body composition in male athletes?, accessed August 28, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC3526124/
96. Depressive Disorder, Treatment-Resistant Recruiting Phase 2 Trials for Quercetin (DB04216) | DrugBank Online, accessed August 28, 2025, https://go.drugbank.com/indications/DBCOND0006117/clinical_trials/DB04216?phase=2&status=recruiting
97. Quercetin: Uses, Health Benefits, Dosage and Side Effects - Consensus: AI Search Engine for Research, accessed August 28, 2025, https://consensus.app/home/blog/quercetin-uses-health-benefits-dosage-and-side-effects/
98. Quercetin: Generic, Supplement Uses, Warnings, Side Effects, Dosage - MedicineNet, accessed August 28, 2025, https://www.medicinenet.com/quercetin/article.htm
99. Quercetin Side Effects: What You Need to Know - Gaia Herbs, accessed August 28, 2025, https://www.gaiaherbs.com/blogs/seeds-of-knowledge/quercetin-side-effects
100. Quercetin: Side Effects, Uses, Dosage, Interactions, Warnings - RxList, accessed August 28, 2025, https://www.rxlist.com/quercetin/generic-drug.htm
101. Quercetin Uses, Benefits & Dosage - Drugs.com, accessed August 28, 2025, https://www.drugs.com/npp/quercetin.html
102. Risk assessment of quercetin dihydrate and rutin in food supplements – “Other substances” - OsloMet ODA, accessed August 28, 2025, https://oda.oslomet.no/oda-xmlui/handle/11250/3135537
103. Rutin and Quercetin – Health Risks of Intake of Food Supplements, accessed August 28, 2025, https://vkm.no/english/riskassessments/allpublications/rutinandquercetinhealthrisksofintakeoffoodsupplements.4.7cc8817a18c33cc0df9bd9bb.html
104. Quercetin: Health Benefits, Side Effects, Uses, Dose & Precautions - RxList, accessed August 28, 2025, https://www.rxlist.com/supplements/quercetin.htm
105. Quercetin - Memorial Sloan Kettering Cancer Center, accessed August 28, 2025, https://www.mskcc.org/cancer-care/integrative-medicine/herbs/quercetin
106. Enhanced Anticoagulant Effect of Warfarin When Co-administered With Quercetin - PMC, accessed August 28, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC9608098/
107. Quercetin: Safety and precautions - CancerChoices, accessed August 28, 2025, https://cancerchoices.org/therapy/quercetin/safety/
108. cancerchoices.org, accessed August 28, 2025, https://cancerchoices.org/therapy/quercetin/safety/#:~:text=Quercetin%20can%20interact%20with%20several,(Cozaar)%2C%20and%20others.
109. Quercegen gets FDA GRAS notified status for QU995 Quercetin, accessed August 28, 2025, https://pharmaceutical-business-review.com/news/quercegen-gets-fda-gras-notified-status-for-qu995-quercetin-040211/
110. Effects of quercetin on pharmacokinetics of cefprozil in Chinese-Han male volunteers., accessed August 28, 2025, https://www.clinpgx.org/literature/15097084/labelAnnotation